Jonah Cashdan
Principal at Bain Capital
New York, New York
Overview
Work Experience
Board Observer
2025 - Current
Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.
Raised $1,351,550,000.00 from BrightEdge Fund, T. Rowe Price, ArrowMark Partners, Roche, Section 32, Sands Capital Ventures, Artis Ventures (AV), Andreessen Horowitz, ARK Investment Management and Pura Vida Investments.
Principal
2018
Life Sciences
Bain Capital is an alternative investment firm specializing in private equity, venture capital, and credit products.
Board Observer
2023
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Raised $214,849,990.00 from Sanofi Ventures, Eurofarma, RA Capital Management, Bain Capital Life Sciences, Pontifax, Mass General Brigham Ventures, Redmile Group, Samsara BioCapital, BlackRock and Soleus Capital.
Board Observer
2023
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Raised $332,000,000.00 from Bain Capital Life Sciences, SR One, Vivo Capital, Marshall Wace, BlackRock, Venrock Healthcare Capital Partners, HBM Healthcare Investments, Redmile Group, Cormorant Asset Management and T. Rowe Price.
Investment Banking Analyst
2016 - 2018
Healthcare
J.P. Morgan Ventures Energy Corporation provides commodity risk management solutions in both the physical .
Investment Banking Summer Analyst
2015 - 2015
J.P. Morgan Ventures Energy Corporation provides commodity risk management solutions in both the physical .
Research Assistant
2013 - 2015
Biomedical Health Internship
2014 - 2014
Education
Bachelor of Science (BS)
2012 - 2016
High School
2008 - 2012